Illumina, Inc. (ILMN)

240,75 +0,94 (+0,39%) Alla chiusura: 04:00PM EDT

Illumina, Inc.

5200 Illumina Way
San Diego, CA 92122
United States
858 202 4500
https://www.illumina.com

Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 9.800

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Francis A. deSouza	CEO & Director	N/D	N/D	1971
Mr. Sam A. Samad	Chief Financial Officer	1,06M	N/D	1970
Dr. Alexander Aravanis M.D., Ph.D.	CTO & Head of Research and Product Devel.	1,05M	N/D	1977
Mr. Charles E. Dadswell	Sr. VP, Gen. Counsel & Sec.	N/D	N/D	1959
Ms. Susan H. Tousi	Chief Commercial Officer	1,04M	N/D	1969
Stephanie Campos	Pres	N/D	N/D	N/D
Mr. Kevin Carl Pegels	Chief of Global Operations	N/D	N/D	N/D
Mr. Jose A. Torres Jr.	Chief Accounting Officer & VP	N/D	N/D	1975
Ms. Carissa Rollins	Chief Information Officer	N/D	N/D	N/D
Ms. Sallilyn Schwartz	VP of Investor Relations	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

Governance aziendale

L'ISS Governance QualityScore di Illumina, Inc. al 1 maggio 2022 è 5. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 1; diritti degli azionisti: 6; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.